210 related articles for article (PubMed ID: 12692669)
1. Delayed chemotherapy-induced nausea in women treated for breast cancer.
Dibble SL; Isreal J; Nussey B; Casey K; Luce J
Oncol Nurs Forum; 2003; 30(2):E40-7. PubMed ID: 12692669
[TBL] [Abstract][Full Text] [Related]
2. Acupressure for nausea: results of a pilot study.
Dibble SL; Chapman J; Mack KA; Shih AS
Oncol Nurs Forum; 2000; 27(1):41-7. PubMed ID: 10660922
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced vomiting in women treated for breast cancer.
Dibble SL; Casey K; Nussey B; Israel J; Luce J
Oncol Nurs Forum; 2004; 31(1):E1-8. PubMed ID: 14722600
[TBL] [Abstract][Full Text] [Related]
5. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial.
Dibble SL; Luce J; Cooper BA; Israel J; Cohen M; Nussey B; Rugo H
Oncol Nurs Forum; 2007 Jul; 34(4):813-20. PubMed ID: 17723973
[TBL] [Abstract][Full Text] [Related]
6. The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy.
Payne JK
Oncol Nurs Forum; 2002 Oct; 29(9):1334-40. PubMed ID: 12370703
[TBL] [Abstract][Full Text] [Related]
7. Nurses' perceptions of antiemetic effectiveness.
Rhodes VA; McDaniel RW; Simms SG; Johnson M
Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
[TBL] [Abstract][Full Text] [Related]
8. The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer.
Williams SA; Schreier AM
Oncol Nurs Forum; 2004; 31(1):E16-23. PubMed ID: 14722602
[TBL] [Abstract][Full Text] [Related]
9. The relationship of chemotherapy-induced nausea to the frequency of pericardium 6 digital acupressure.
Lee J; Dibble S; Dodd M; Abrams D; Burns B
Oncol Nurs Forum; 2010 Nov; 37(6):E419-25. PubMed ID: 21059575
[TBL] [Abstract][Full Text] [Related]
10. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.
McInnes JA; Knobf MT
Oncol Nurs Forum; 2001 May; 28(4):675-84. PubMed ID: 11383182
[TBL] [Abstract][Full Text] [Related]
11. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
12. Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer.
Roscoe JA; Matteson SE; Morrow GR; Hickok JT; Bushunow P; Griggs J; Qazi R; Smith B; Kramer Z; Smith J
J Pain Symptom Manage; 2005 Apr; 29(4):376-84. PubMed ID: 15857741
[TBL] [Abstract][Full Text] [Related]
13. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
Warr DG; Hesketh PJ; Gralla RJ; Muss HB; Herrstedt J; Eisenberg PD; Raftopoulos H; Grunberg SM; Gabriel M; Rodgers A; Bohidar N; Klinger G; Hustad CM; Horgan KJ; Skobieranda F
J Clin Oncol; 2005 Apr; 23(12):2822-30. PubMed ID: 15837996
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant.
Grote T; Hajdenberg J; Cartmell A; Ferguson S; Ginkel A; Charu V
J Support Oncol; 2006 Sep; 4(8):403-8. PubMed ID: 17004515
[TBL] [Abstract][Full Text] [Related]
16. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
17. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study.
So WK; Marsh G; Ling WM; Leung FY; Lo JC; Yeung M; Li GK
Oncol Nurs Forum; 2009 Jul; 36(4):E205-14. PubMed ID: 19581224
[TBL] [Abstract][Full Text] [Related]
18. Anticipatory nausea and vomiting in an ambulatory medical oncology population.
Fetting JH; Wilcox PM; Iwata BA; Criswell EL; Bosmajian LS; Sheidler VR
Cancer Treat Rep; 1983 Dec; 67(12):1093-8. PubMed ID: 6652626
[TBL] [Abstract][Full Text] [Related]
19. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial.
Molassiotis A; Yung HP; Yam BM; Chan FY; Mok TS
Support Care Cancer; 2002 Apr; 10(3):237-46. PubMed ID: 11904789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]